Calidi Biotherapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Calidi Biotherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2022 to Q2 2024.
  • Calidi Biotherapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 5.33M shares, a 507% increase year-over-year.
  • Calidi Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 16.9M shares, a 98.6% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 5.33M +4.45M +507% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 35.6M +26.9M +311% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 16.9M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 14.3M +5.74M +67.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 878K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 8.66M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 8.57M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.